Contact

Company Overview

Nona Biosciences is a global biotechnology company committed to cutting-edge technology innovation and provides a total solution from “Idea to IND” (I to I™), ranging from target validation and antibody discovery through preclinical research. The integrated antibody discovery services range from antigen preparation, animal immunization, highly robust antibody screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging advantages of Harbour Mice® technology and the experienced therapeutic antibody discovery team.

Harbour Mice® generate fully human monoclonal antibodies in a traditional two heavy and two light chain (H2L2) format, and a heavy chain only (HCAb) format. Integrating Harbour Mice® with highly robust antibody screening platforms, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs.

Empower Global Biotherapeutics 

Harbour Mice® HCAb & H2L2
HCAb PLUS™
Idea to IND

Company Overview

Nona Biosciences is a global biotechnology company committed to cutting-edge technology innovation and provides a total solution from “Idea to IND” (I to I™), ranging from target validation and antibody discovery through preclinical research. The integrated antibody discovery services range from antigen preparation, animal immunization, highly robust antibody screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging advantages of Harbour Mice® technology and the experienced therapeutic antibody discovery team.

Harbour Mice® generate fully human monoclonal antibodies in a traditional two heavy and two light chain (H2L2) format, and a heavy chain only (HCAb) format. Integrating Harbour Mice® with highly robust antibody screening platforms, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs.

Harbour Mice® HCAb & H2L2
HCAb PLUS™
Idea to IND

Our Management Team

Chairman

Jingsong Wang
MD, PhD

Read Bio

Jingsong Wang MD, PhD

Chairman

Dr. Jingsong Wang is Chairman of Nona Biosciences. Prior to that, Dr. Wang served as Head of China R&D and Head of Translational Medicine, Asia Pacific, at Sanofi. He is a former attending physician and clinical fellow at Harvard Medical School. Dr. Wang received his Ph.D. in Molecular Pharmacology from China Pharmaceutical University and has also completed a Molecular Immunology Research Fellowship at Dr. Laurie Glimcher’s laboratory at the Harvard School of Public Health.

Popup/Modal Windows without JavaScript

Chief Scientific Officer

Yiping Rong
PhD

Read Bio

Yiping Rong
PhD

Chief Scientific Officer

Dr. Yiping Rong is our Chief Scientific Officer. He is a well-recognized scientist with about 20 years’ experience of biomedical research and drug discovery. Dr. Rong used to work at Sanofi, JNJ and Roche and built strong expertise in cancer biology and pharmacology. He led and contributed to >15 programs entering clinical trials. He is also involved in translational research work for a few drugs. Multiple mAb or bispecific antibodies generated from his team were out licensed to MNCs. Some highly innovative first-in-class projects are in clinical trials. He worked on apoptosis, epigenetics, immuno-oncology, and cancer cell signaling fields and led the drug discovery projects including kinase, enzyme, receptor/ligand, protein-protein-interaction targets by small molecules or monoclonal antibodies. Dr. Rong received his Ph.D. degree in Pharmacology from Case Western Reserve University (Cleveland, Ohio). He is the member of American Association of Cancer Research and has more than twenty publications in cancer research field, including Nature Genetics, Molecular Cell, PNAS papers. He is also the inventor of dozens of patents in drug discovery field.

Head of Business Development

Jiyong Zhang
PhD

Read Bio

Jiyong Zhang
PhD

Head of Business Development

Dr. Jiyong Zhang leads business development at Nona Biosciences, bringing vision and dedication to strategic growth and client satisfaction. With 15 years of experience in biotherapeutic research and development, Dr. Zhang’s understanding of market dynamics and ability to identify mission-aligned opportunities are evident.

Before overseeing business development at Nona, Dr. Zhang played key roles at Alexion and Abbvie, contributing to antibody discovery, engineering, and bispecific antibody R&D. His scientific experiences and knowledge in biotherapeutic innovation makes him a forward-thinking strategist focused on enhancing service offerings to meet evolving client needs.

With Dr. Zhang and his team driving business development, Nona Biosciences is poised to offer innovative solutions and unparalleled service. This solidifies the company’s position as a trusted and client-focused drug discovery partner in the dynamic landscape of biotherapeutic innovation.

Vice President, Head of
External Innovation

Joe Zhao
PhD

Senior Vice President, Head
of Scientific Operation

Louis Liu

Chief Technology Officer

Yun He
PhD

Head of Biology

Musheng Bao
PhD

Popup/Modal Windows without JavaScript

Scientific Advisory Board

Academy Professor of Cell Biology, Erasmus Medical Center, Rotterdam

Frank Grosveld PhD

Venture Partner, Third Rock Ventures 

Robert Kamen
PhD

Chief Scientific Advisor, Nona Biosciences

Steve Arkinstall PhD

CSO, SalvaRx Therapeutics BoD, Meditope Biosciences Chair, NeoTX SAB

Robert Kramer
PhD

Popup/Modal Windows without JavaScript

Former CEO, Adello Biologics

Peter Moesta
PhD

Academician of Chinese Academy of Engineering

Zhigang Tian
PhD

Empower Global Biotherapeutics with Nona Bioscienses

Explore more with us

Empower Global Biotherapeutics with Nona Bioscienses

Explore more with us

Get started with a career at Nona

See open positions
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound
Contact